Enveric Biosciences, Inc. (ENVB) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Naples, FL, 美国. 现任CEO为 Joseph Edward Tucker.
ENVB 拥有 IPO日期为 2015-05-04, 5 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.16M.
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
